IP Library › Assignment 021371/0769
Patent Assignment
Reel/Frame 021371/0769

Change of Name

Recorded: 2008-08-11 Pages: 8
Assignor
Assignee
NABRIVA THERAPEUTICS AG
LEBERSTRASSE 20, VIENNA, A-1112, AUSTRIA
Covered Properties (7)
Antibacterial Mutilins
Patent: 7,169,804 →
Application: 10/363,840 →
Publication: US 2004/0102482
Use of Pleuromutilins for the Treatment of Disorders Caused by Helicobacter Pylori
Patent: 7,790,749 →
Application: 10/510,532 →
Publication: US 2005/0131023
Pleuromutilin Derivatives as Antimicrobials
Patent: 7,612,103 →
Application: 10/521,926 →
Publication: US 2005/0250811
Cephalosporins
Patent: 7,485,632 →
Application: 10/527,882 →
Publication: US 2005/0234233
Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
Application: 11/294,066 →
Publication: US 2006/0223789
Antibacterial Mutilins
Patent: 7,569,587 →
Application: 11/652,812 →
Publication: US 2007/0135483
Tuberculosis Treatment Using Pleuromutilin Derivatives
Patent: 8,088,823 →
Application: 11/818,094 →
Publication: US 2007/0270404
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 17, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018783/0780 →
Assignment of Assignor's Interest Feb 22, 2007
From: ASCHER, GERD; HEILMAYER, WERNER; SCHRANZ, MICHAEL; WIESER, JOSEF
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018932/0435 →
Assignment of Assignor's Interest Feb 22, 2007
From: ASCHER, GERD; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018931/0846 →
Change of Name Feb 23, 2007
From: BIOCHEMIE GESELLSCHAFT M.B.H.
To: SANDOZ GMBH
Reel/Frame 018935/0751 →
Assignment of Assignor's Interest Mar 20, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019046/0854 →
Assignment of Assignor's Interest Mar 21, 2007
From: BERNER, HEINZ; KERBER, GABRIELE
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019049/0959 →
Assignment of Assignor's Interest Jun 13, 2007
From: ASCHER, GERD; BERNER, HEINZ; MANG, ROSEMARIE
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019479/0230 →
Assignment of Assignor's Interest Jun 20, 2007
From: SANDOZ GMBH
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019457/0912 →
Security Interest Aug 28, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033647/0657 →
Release of Security Interest Jan 11, 2016
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037455/0436 →
Intellectual Property Security Agreement Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Release of Security Interest Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest. Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Nunc Pro Tunc Assignment Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →